KR20160026909A - 미세유체 협동 효소 증강 반응성(ceer) 면역검정 - Google Patents

미세유체 협동 효소 증강 반응성(ceer) 면역검정 Download PDF

Info

Publication number
KR20160026909A
KR20160026909A KR1020157036806A KR20157036806A KR20160026909A KR 20160026909 A KR20160026909 A KR 20160026909A KR 1020157036806 A KR1020157036806 A KR 1020157036806A KR 20157036806 A KR20157036806 A KR 20157036806A KR 20160026909 A KR20160026909 A KR 20160026909A
Authority
KR
South Korea
Prior art keywords
microcarriers
encoded
cancer
microcarrier
antibodies
Prior art date
Application number
KR1020157036806A
Other languages
English (en)
Korean (ko)
Inventor
인디아 제페린
카티아 마고노바
Original Assignee
네스텍 소시에테아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 네스텍 소시에테아노님 filed Critical 네스텍 소시에테아노님
Publication of KR20160026909A publication Critical patent/KR20160026909A/ko

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
KR1020157036806A 2013-07-09 2014-06-30 미세유체 협동 효소 증강 반응성(ceer) 면역검정 KR20160026909A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361844308P 2013-07-09 2013-07-09
US61/844,308 2013-07-09
PCT/EP2014/063846 WO2015003945A1 (fr) 2013-07-09 2014-06-30 Essai immunologique microfluidique à réactivité renforcée par collaboration enzymatique ceer

Publications (1)

Publication Number Publication Date
KR20160026909A true KR20160026909A (ko) 2016-03-09

Family

ID=51022887

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157036806A KR20160026909A (ko) 2013-07-09 2014-06-30 미세유체 협동 효소 증강 반응성(ceer) 면역검정

Country Status (7)

Country Link
EP (1) EP3019867A1 (fr)
JP (1) JP2016527495A (fr)
KR (1) KR20160026909A (fr)
CN (1) CN105378481A (fr)
AU (1) AU2014289499A1 (fr)
CA (1) CA2912318A1 (fr)
WO (1) WO2015003945A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200061692A (ko) * 2018-11-26 2020-06-03 주식회사 엘지화학 다중 면역 진단 기기

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107190050B (zh) * 2016-03-14 2020-10-27 华东理工大学 一种hrp活性测定及h2o2浓度检测的试剂盒及其应用
WO2021056064A1 (fr) * 2019-09-23 2021-04-01 Macquarie University Traitement de tauopathies
CN112574284B (zh) * 2020-12-29 2023-08-08 珠海碳云诊断科技有限公司 多肽、其组合物、包含其的试剂盒及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532138A (en) 1990-04-26 1996-07-02 Behringwerke Ag Method and kits for determining peroxidatively active catalysts
US5332662A (en) 1992-07-31 1994-07-26 Syntex (U.S.A.) Inc. Methods for determining peroxidatively active substances
JP3498960B2 (ja) 1993-09-03 2004-02-23 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 蛍光酸素チャンネリングイムノアッセイ
CN1566951A (zh) * 2003-06-16 2005-01-19 中国科学院大连化学物理研究所 一种基于微流控芯片的细胞分选方法及其专用芯片
US20080076139A1 (en) * 2006-09-21 2008-03-27 Sharat Singh Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells
US8409877B2 (en) * 2006-12-29 2013-04-02 Intel Corporation Enzymatic signal generation and detection of binding complexes in stationary fluidic chip
WO2009108637A1 (fr) 2008-02-25 2009-09-03 Prometheus Laboratories, Inc. Sélection d’un médicament pour le traitement du cancer du sein à partir des matrices d’anticorps
EP2367633B1 (fr) * 2008-12-23 2019-03-27 MyCartis N.V. Dispositif de dosage et procédé pour effectuer des dosages biologiques
US20120149128A1 (en) * 2009-02-23 2012-06-14 Victor Manneh Assays and assay devices
EP2312393A1 (fr) 2009-10-14 2011-04-20 Biocartis SA Procédé pour la production de microparticules
EP2484447A1 (fr) 2011-02-07 2012-08-08 Biocartis SA Micro-supports codés améliorés, système d'analyse les utilisant et procédé d'exécution d'une analyse
KR101851425B1 (ko) * 2011-09-02 2018-04-23 네스텍 소시에테아노님 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링
WO2013055829A1 (fr) * 2011-10-11 2013-04-18 Nestec S.A. Dosage de proximité pour la détection de l'expression et de l'activation de protéines de signalisation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200061692A (ko) * 2018-11-26 2020-06-03 주식회사 엘지화학 다중 면역 진단 기기

Also Published As

Publication number Publication date
WO2015003945A1 (fr) 2015-01-15
JP2016527495A (ja) 2016-09-08
CA2912318A1 (fr) 2015-01-15
AU2014289499A1 (en) 2015-11-19
EP3019867A1 (fr) 2016-05-18
CN105378481A (zh) 2016-03-02

Similar Documents

Publication Publication Date Title
US20220082559A1 (en) Systems and methods for performing immunoassays
Takeuchi et al. Antibody-conjugated signaling nanocavities fabricated by dynamic molding for detecting cancers using small extracellular vesicle markers from tears
Shao et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
TWI708058B (zh) 阿茲海默症及其他神經退化性疾病之生物標記及診斷方法
CN109490528A (zh) 外泌体分析及癌症诊断方法
Jain Role of proteomics in the development of personalized medicine
Iqbal et al. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation
Wu et al. Identifying the phenotypes of tumor-derived extracellular vesicles using size-coded affinity microbeads
KR20160026909A (ko) 미세유체 협동 효소 증강 반응성(ceer) 면역검정
US20220397528A1 (en) Systems and methods for rapid, sensitive multiplex immunoassays
Ahn et al. Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples
Jiang et al. Rapid enrichment and detection of extracellular vesicles enabled by CuS-enclosed microgels
Chan et al. Prostate cancer detection: A systematic review of urinary biosensors
Hwang et al. Aptamer-conjugated live human immune cell based biosensors for the accurate detection of C-reactive protein
EP3123175B1 (fr) Méthode d'identification d'un biomarqueur indiquant une réaction médicamenteuse réduite à l'aide d'une analyse de variation thermique
Shohatee et al. Hydrogel-based suspension array for biomarker detection using horseradish peroxidase-mediated silver precipitation
US20170089912A1 (en) Collaborative enzyme enhanced reactive (ceer) immunoassay using flow cytometry
Baird et al. Tumor cell detection by mass spectrometry using signal ion emission reactive release amplification
CN113718031B (zh) 一种卵巢癌早期诊断组合物的建立
US20160131643A1 (en) Microfluidic collaborative enzyme enhanced reactive ceer immunoassay
WO2024001798A1 (fr) Procédé de détection de polarisation de fluorescence de vésicules extracellulaires basé sur des aptamères d'acides nucléiques et son application
Ashley et al. Functionalization of hybrid surface microparticles for in vitro cellular antigen classification
US20210181195A1 (en) Methods, conjugates and systems
KR102343240B1 (ko) 대장암 환자에서 세툭시맙에 대한 내성 예측용 바이오마커 조성물
Mousavi et al. A Simple Aptamer-Based Nanoconjugate Assay for Diagnosis of Chronic Myeloid Leukemia

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination